Gilead to acquire Tubulis for up to $5 billion to strengthen its oncology portfolio
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
Cyble’s 2026 healthcare threat report flags a sharp rise in Asia-focused ransomware, with hospitals, elderly care, and diagnostic systems increasingly in cybercriminal crosshairs
The partnership aims to accelerate clinical trial timelines, boost data quality, and improve decision-making for sponsors worldwide
TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners
Approval for 5 mg and 10 mg strengths, bioequivalent to Farxiga®, strengthens Lupin’s anti-diabetic portfolio in US market
The trial also demonstrated significant improvements across multiple secondary endpoints
New adult supplement combines 26 vitamins, minerals and botanicals to address stress, energy, immunity and cognitive wellness in one daily tablet
Subscribe To Our Newsletter & Stay Updated